Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Theratechnologies Inc. (T:TH)

Business Focus: Biopharmaceuticals

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for TH within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Nov 26, 2021 13:06 ET
Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category
Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
1.66
--
--
Price to Sales - TTM
4.51
6.68
11.80
Price to Book - most recent quarter
11.65
5.67
2.88
Price to Cash Flow per share - TTM
--
--
13.85
Price to Free Cash Flow per share - TTM
--
--
36.08
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 15, 2021235,24717,638
Oct 31, 2021217,609-13,814
Oct 15, 2021231,4231,699
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Theratechnologies Inc. is a Canada-based biopharmaceutical company focused on the development and commercialization of therapies addressing unmet medical needs. The Company has two approved products: EGRIFTA SV in the United States, and Trogarzo in the United States, the European Union and the United Kingdom. EGRIFTA SV (tesamorelin for injection) is developed for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy. Trogarzo (ibalizumab-uiyk) is developed for HIV treatment. The treatment is infused every two weeks. It is a new class of antiretrovirals (ARV), and is a long-acting ARV therapy that can lead to an undetectable viral load in combination with other ARVs. The Company markets its prescription products in the United States, Europe and Canada. Its research pipeline is focused on specialized therapies addressing unmet medical needs in HIV, oncology and non-alcoholic steatohepatitis (NASH).

See business summary

 

Twitter

Search (past week) for $TH.CA

  • No tweets found